Project Leaders: Prof. Stefan Endres, Coordinator of IMMUTRAIN, Director of the Division of Clinical Pharmacology, Ludwig-Maximilians-Universitaet, Munich
PD Dr. Sebastian Kobold, Scientific Coordinator of IMMUTRAIN, Group Leader of Immunopharmacology, Division of Clinical Pharmacology, Ludwig Maximilians Universitaet, Munich

Description of the project: Adoptive T cell transfer for cancer therapy The project will be part of the IMMUTRAIN-Workpackage 1: Combination of antibodies with adoptive T cell transfer. It will comprise: Genetic engineering of T-cells for
enhanced functionality against cancer- Validation in different animal models – Function analysis and description of cellular product.

Application deadline September 9th 2016

Find out more